ArticleExperimental and therapeutic medicine2017

Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysis.

Jianrong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.